Fig. 4.
Fig. 4. Effect of anti–VCAM-1 and anti–VLA-4 antibodies on endothelial CD31-induced enhancement of eosinophil adhesion to IL-4–stimulated vascular endothelial cells. IL-4–stimulated HUVECs were preincubated with anti-CD31 MoAb or control mouse IgG (10 μg/mL each) for 10 minutes at 37°C. After washing HUVECs, the adhesion assay of 51Cr-labeled eosinophils to HUVECs was performed in the presence or absence of anti–VCAM-1 MoAb or anti–VLA-4 MoAb (10 μg/mL each). Data are the means ± SD for 5 experiments. *Significantly different from the mean value of the control response (*P < .001). **Significantly different from the mean value of the corresponding control response (**P < .001).

Effect of anti–VCAM-1 and anti–VLA-4 antibodies on endothelial CD31-induced enhancement of eosinophil adhesion to IL-4–stimulated vascular endothelial cells. IL-4–stimulated HUVECs were preincubated with anti-CD31 MoAb or control mouse IgG (10 μg/mL each) for 10 minutes at 37°C. After washing HUVECs, the adhesion assay of 51Cr-labeled eosinophils to HUVECs was performed in the presence or absence of anti–VCAM-1 MoAb or anti–VLA-4 MoAb (10 μg/mL each). Data are the means ± SD for 5 experiments. *Significantly different from the mean value of the control response (*P < .001). **Significantly different from the mean value of the corresponding control response (**P < .001).

Close Modal

or Create an Account

Close Modal
Close Modal